Therapeutic Targets to Alter Inflammation, Type 2 Diabetes

Status
Not open for further replies.

Northerner

Admin (Retired)
Relationship to Diabetes
Type 1
New research from Boston University School of Medicine (BUSM) reveals that B cells regulate obesity-associated inflammation and type 2 diabetes through two specific mechanisms. The study, published in the Proceedings of the National Academy of Sciences, indicates the importance of continuing to explore B cells as a therapeutic target to treat these diseases. Barbara Nikolajczyk, PhD, associate professor of microbiology at BUSM, is the study's senior author.

The incidence of diabetes continues to rise at alarming rates. According to the National Institute of Diabetes and Digestive and Kidney Diseases, the disease now affects approximately 25.8 million Americans. In 2007, the National Institutes of Health estimated that the direct and indirect costs of diabetes were a staggering $174 billion.

http://www.sciencedaily.com/releases/2013/03/130312134744.htm
 
Status
Not open for further replies.
Back
Top